MOH SEC-Einreichungen - Molina Healthcare, Inc.- Geschäftsbericht, Stimmrechtsmitteilung, Prospekt

Grundlegende Statistiken

LEI	549300NQQCEQ46YHZ591
CIK	1179929

SEC Filings

All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis. These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Molina Healthcare, Inc.

SEC Filings (Chronological Order)

Diese Seite bietet eine vollständige, chronologische Liste der SEC-Meldungen, ausgenommen Meldungen zu Eigentumsverhältnissen, die wir an anderer Stelle bereitstellen.

July 23, 2026	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2026 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 00
July 22, 2026	EX-99.1	Molina Healthcare Reports Second Quarter 2026 Financial Results Increases Full Year 2026 Earnings Guidance News Release Investor Contact: Jeffrey Geyer, [email protected], 305-317-3012 Media Contact: Caroline Zubieta, [email protected], 562-542-1845 Molina Healthcare Reports Second Quarter 2026 Financial Results Increases Full Year 2026 Earnings Guidance Long Beach, Calif., July 22, 2026 – Molina Healthcare, Inc. (NYSE: MOH) (the “Company”) today reported second qua
July 22, 2026	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 22, 2026 MOLINA HEALTHCARE, UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 22, 2026 MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 1-31719 13-4204626 (State or other jurisdiction of incorporation) (Commission Fil
June 10, 2026	EX-99.1	Molina Healthcare Wins Illinois Medicaid Contract Exhibit 99.1 NEWS RELEASE Investor Contact: Jeff Geyer, [email protected], 305-317-3012 Media Contact: Caroline Zubieta, [email protected], 562-542-1845 Molina Healthcare Wins Illinois Medicaid Contract LONG BEACH, Calif., June 10, 2026 – Molina Healthcare, Inc. (NYSE: MOH) (“Molina”) announced today that the Illinois Department of Healthcare and Family Service
June 10, 2026	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 10, 2026 MOLINA HEALTHCARE, UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 10, 2026 MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 1-31719 13-4204626 (State or other jurisdiction of incorporation) (Commission Fil
May 27, 2026	S-8	As filed with the Securities and Exchange Commission on May 27, 2026 As filed with the Securities and Exchange Commission on May 27, 2026 Registration No.
May 27, 2026	EX-FILING FEES	Table 1: Newly Registered Securities Calculation of Filing Fee Tables S-8 MOLINA HEALTHCARE, INC. Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee 1 Equity Common stock, $0.001 par value per share 457(a) 1,500,000 $ 178.97 $ 268,455,000.00 0.0001381 $ 37,073.64 Tot
May 11, 2026	EX-10.1	AMENDMENT NUMBER ONE TO THE MOLINA HEALTHCARE, INC. 2025 EQUITY INCENTIVE PLAN AMENDMENT NUMBER ONE TO THE MOLINA HEALTHCARE, INC. 2025 EQUITY INCENTIVE PLAN Molina Healthcare, Inc. adopts the following amendment to the Molina Healthcare, Inc. 2025 Equity Incentive Plan (the “Plan”), effective May 6, 2026. Unless otherwise defined herein, any capitalized terms shall have the meaning set forth in the Plan. 1. Section 4.1 of the Plan is hereby amended and restated in its entir
May 11, 2026	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 11, 2026 (May 6, 2026) MOLINA UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 11, 2026 (May 6, 2026) MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 1-31719 13-4204626 (State or other jurisdiction of incorporation) (C
May 11, 2026	EX-3.2	#2008106v1 AMENDED AND RESTATED BYLAWS OF MOLINA HEALTHCARE, INC. a Delaware corporation (as Amended and Restated Effective May 6, 2026) #2008106v1 TABLE OF CONTENTS Page ARTICLE I OFFICES ............................................................. exhibit32amendedandresta #2008106v1 AMENDED AND RESTATED BYLAWS OF MOLINA HEALTHCARE, INC.
May 11, 2026	EX-3.1	CERTIFICATE OF AMENDMENT TO THE CERTIFICATE OF INCORPORATION MOLINA HEALTHCARE, INC. Pursuant to §242 of the General Corporation Law of the State of Delaware CERTIFICATE OF AMENDMENT TO THE CERTIFICATE OF INCORPORATION OF MOLINA HEALTHCARE, INC.
May 8, 2026	EX-99.1	EXHIBIT 99.1 Exhibit 99.1
May 8, 2026	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 8, 2026 MOLINA HEALTHCARE, IN UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 8, 2026 MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 1-31719 13-4204626 (State or other jurisdiction of incorporation) (Commission File
April 23, 2026	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2026 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 0
April 22, 2026	EX-99.1	Molina Healthcare Reports First Quarter 2026 Financial Results Reaffirms Full Year 2026 Premium Revenue and Adjusted Earnings Guidance News Release Investor Contact: Jeffrey Geyer, [email protected], 305-317-3012 Media Contact: Caroline Zubieta, [email protected], 562-951-1588 Molina Healthcare Reports First Quarter 2026 Financial Results Reaffirms Full Year 2026 Premium Revenue and Adjusted Earnings Guidance Long Beach, Calif., April 22, 2026 – Molina Healthcare, Inc. (NYSE: MOH) (the “Compan
April 22, 2026	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 22, 2026 MOLINA HEALTHCARE, UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 22, 2026 MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 1-31719 13-4204626 (State or other jurisdiction of incorporation) (Commission Fi
March 23, 2026	DEFA14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ___) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant þ Filed by a Party other than the Registrant ¨ Check the appropriate box: ú Preliminary Proxy Statement ú Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)
March 23, 2026	ARS	ARS Company Profile Molina Healthcare, Inc., a FORTUNE 500 company, provides managed healthcare services under the Medicaid and Medicare programs and through the state insurance marketplaces. As of December 31, 2025, Molina Healthcare served approximately 5.5 million members. For more information about Molina Healthcare, please visit molinahealthcare.com. Line of Business Profile 2025 Membership by Li
March 23, 2026	DEF 14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ___) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant þ Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)
March 13, 2026	PRE 14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ___) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant þ Filed by a Party other than the Registrant ¨ Check the appropriate box: þ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)
February 26, 2026	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 26, 2026 MOLINA HEALTHCA UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 26, 2026 MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 1-31719 13-4204626 (State or other jurisdiction of incorporation) (Commission
February 10, 2026	EX-21.1	LIST OF SUBSIDIARIES Name Jurisdiction of Incorporation 2028 West Broadway, LLC Delaware Central Health Plan of California, Inc. California ConnectiCare Holding Company, Inc. Connecticut ConnectiCare Capital, LLC(6) Connecticut ConnectiCare, Inc.(7) EXHIBIT 21.1 LIST OF SUBSIDIARIES Name Jurisdiction of Incorporation 2028 West Broadway, LLC Delaware Central Health Plan of California, Inc. California ConnectiCare Holding Company, Inc. Connecticut ConnectiCare Capital, LLC(6) Connecticut ConnectiCare, Inc.(7) Connecticut ConnectiCare Insurance Company, Inc.(7) Connecticut ConnectiCare Benefits, Inc.(8) Connecticut MHAZ, Inc.* Arizona Molina Hea
February 10, 2026	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number 1-31719 MOLINA HEALTHCARE
February 6, 2026	EX-10.1	FIRST AMENDMENT TO CREDIT AGREEMENT Exhibit 10.1 FIRST AMENDMENT TO CREDIT AGREEMENT THIS FIRST AMENDMENT TO CREDIT AGREEMENT, dated as of February 4, 2026 (this “Amendment”), is entered into between Molina Healthcare, Inc., a Delaware corporation (the “Borrower”), each of the Lenders party hereto constituting Required Lenders (as defined in the Existing Credit Agreement) and Truist Bank, in its capacity as administrative agent (the
February 6, 2026	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 6, 2026 (February 4, 202 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 6, 2026 (February 4, 2026) MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-31719 13-4204626 (State or other jurisdiction of incorp
February 5, 2026	EX-99.1	Molina Healthcare Reports Fourth Quarter and Year-End 2025 Financial Results Introduces Full Year 2026 Revenue and Earnings Guidance News Release Investor Contact: Jeffrey Geyer, [email protected], 305-317-3012 Media Contact: Caroline Zubieta, [email protected], 562-951-1588 Molina Healthcare Reports Fourth Quarter and Year-End 2025 Financial Results Introduces Full Year 2026 Revenue and Earnings Guidance Long Beach, Calif., February 5, 2026 – Molina Healthcare, Inc. (NYSE: MOH) (the “Compan
February 5, 2026	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 5, 2026 MOLINA HEALTHCAR UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 5, 2026 MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 1-31719 13-4204626 (State or other jurisdiction of incorporation) (Commission
November 20, 2025	EX-10.1	CREDIT AGREEMENT dated as of November 20, 2025 MOLINA HEALTHCARE, INC., as the Borrower, THE LENDERS FROM TIME TO TIME PARTY HERETO, TRUIST BANK, as Administrative Agent, Swingline Lender and Issuing Bank TRUIST SECURITIES, INC. BARCLAYS BANK PLC BOF Exhibit 10.1 CUSIP: 60855QAP7 CREDIT AGREEMENT dated as of November 20, 2025 among MOLINA HEALTHCARE, INC., as the Borrower, THE LENDERS FROM TIME TO TIME PARTY HERETO, TRUIST BANK, as Administrative Agent, Swingline Lender and Issuing Bank TRUIST SECURITIES, INC. BARCLAYS BANK PLC BOFA SECURITIES, INC. DEUTSCHE BANK SECURITIES INC. GOLDMAN SACHS LENDING PARTNERS, LLC JPMORGAN CHASE BANK, N.A. MUF
November 20, 2025	EX-99.1	Molina Healthcare Announces Closing of Offering of $850 Million of 6.500% Senior Notes Due 2031 Exhibit 99.1 News Release Investor Contact: Jeff Geyer, [email protected], 305-317-3012 Media Contact: Caroline Zubieta, [email protected], 562-951-1588 Molina Healthcare Announces Closing of Offering of $850 Million of 6.500% Senior Notes Due 2031 Long Beach, Calif., November 20, 2025 – Molina Healthcare, Inc. (NYSE: MOH) (the “Company”) today announced the cl
November 20, 2025	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 20, 2025 MOLINA HEALTHCA UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 20, 2025 MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-31719 13-4204626 (State or other jurisdiction of incorporation) (Commissi
November 20, 2025	EX-4.1	MOLINA HEALTHCARE, INC. 6.500% Senior Notes due 2031 Dated as of November 20, 2025 U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION as Trustee TABLE OF CONTENTS Exhibit 4.1 Execution Version MOLINA HEALTHCARE, INC. $850,000,000 6.500% Senior Notes due 2031 INDENTURE Dated as of November 20, 2025 U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION as Trustee TABLE OF CONTENTS Page ARTICLE 1 DEFINITIONS AND INCORPORATION BY REFERENCE 1 Section 1.01 Definitions 1 Section 1.02 Other Definitions 14 Section 1.03 Incorporation by Reference of Trust Indenture Act 15 Se
November 18, 2025	EX-99.1	Molina Healthcare Announces Pricing of $850 Million of 6.500% Senior Notes Due 2031 Exhibit 99.1 News Release Investor Contact: Jeff Geyer, [email protected], 305-317-3012 Media Contact: Caroline Zubieta, [email protected], 562-951-1588 Molina Healthcare Announces Pricing of $850 Million of 6.500% Senior Notes Due 2031 Long Beach, Calif., November 17, 2025 – Molina Healthcare, Inc. (NYSE: MOH) (the “Company”) today announced that it priced $85
November 18, 2025	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 17, 2025 MOLINA HEALTHCA UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 17, 2025 MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-31719 13-4204626 (State or other jurisdiction of incorporation) (Commissi
November 17, 2025	EX-99.1	Molina Healthcare Announces Proposed Offering of $750 Million of Senior Notes Due 2031 Exhibit 99.1 News Release Investor Contact: Jeff Geyer, [email protected], 305-317-3012 Media Contact: Caroline Zubieta, [email protected], 562-951-1588 Molina Healthcare Announces Proposed Offering of $750 Million of Senior Notes Due 2031 Long Beach, Calif., November 17, 2025 – Molina Healthcare, Inc. (NYSE: MOH) (the “Company”) today announced that it intends
November 17, 2025	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 17, 2025 MOLINA HEALTHCA UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 17, 2025 MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-31719 13-4204626 (State or other jurisdiction of incorporation) (Commissi
November 14, 2025	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 14, 2025 MOLINA HEALTHCA UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 14, 2025 MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 1-31719 13-4204626 (State or other jurisdiction of incorporation) (Commission
November 14, 2025	EX-99.1	Molina Healthcare Awarded New Florida Medicaid Contract Exhibit 99.1 NEWS RELEASE Investor Contact: Jeff Geyer, [email protected], 305-317-3012 Media Contact: Caroline Zubieta, [email protected], 562-951-1588 Molina Healthcare Awarded New Florida Medicaid Contract LONG BEACH, Calif., Nov. 14, 2025 – Molina Healthcare, Inc. (NYSE: MOH) (“Molina”) announced today that the Florida Agency for Health Care Administration
October 23, 2025	EX-10.2	#705438v1 MOLINA HEALTHCARE, INC. 2025 EQUITY INCENTIVE PLAN PERFORMANCE STOCK UNIT AWARD AGREEMENT Participant: ______________________________________ Grant Date: ______________________________________ Target Number of Performance Units1: __________ molina-performancestocku #705438v1 MOLINA HEALTHCARE, INC. 2025 EQUITY INCENTIVE PLAN PERFORMANCE STOCK UNIT AWARD AGREEMENT Participant: Grant Date: Target Number of Performance Units1: Performance Period for the Award: to Vesting1,2 The Award shall vest and become nonforfeitable as provided in Section 2 of the attached Terms and Conditions of Performance Unit Award (the “Terms”). THIS PERFORMANC
October 23, 2025	EX-10.1	#705435v1 Molina Healthcare, Inc. 2025 Equity Incentive Plan Restricted Stock Award Agreement Grantee: __________________________ Grant Date: __________________________ Total Number of Shares Granted (the “Shares”): __________________________ _______ molina-restrictedstockaw #705435v1 Molina Healthcare, Inc. 2025 Equity Incentive Plan Restricted Stock Award Agreement Grantee: Grant Date: Total Number of Shares Granted (the “Shares”): This RESTRICTED STOCK AWARD AGREEMENT (this “Agreement”) effective as of the Grant Date is between Molina Healthcare, Inc., a Delaware corporation (the “Company”), and Grantee, an employee of the Company or one of
October 23, 2025	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file numbe
October 22, 2025	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 22, 2025 MOLINA HEALTHCAR UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 22, 2025 MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 1-31719 13-4204626 (State or other jurisdiction of incorporation) (Commission
October 22, 2025	EX-99.1	Molina Healthcare Reports Third Quarter 2025 Financial Results Revises Full Year 2025 Guidance News Release Investor Contact: Jeffrey Geyer, [email protected], 305-317-3012 Media Contact: Caroline Zubieta, [email protected], 562-951-1588 Molina Healthcare Reports Third Quarter 2025 Financial Results Revises Full Year 2025 Guidance Long Beach, Calif., October 22, 2025 – Molina Healthcare, Inc. (NYSE: MOH) (the “Company”) today reported third quarter 2025
August 12, 2025	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 12, 2025 MOLINA HEALTHCARE UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 12, 2025 MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 1-31719 13-4204626 (State or other jurisdiction of incorporation) (Commission F
August 12, 2025	EX-10.1	FOURTH AMENDMENT CREDIT AGREEMENT dated as of August 12, 2025 MOLINA HEALTHCARE, INC., as the Borrower, THE LENDERS FROM TIME TO TIME PARTY HERETO, TRUIST BANK, as Administrative Agent, Swingline Lender and Issuing Bank TRUIST SECURITIES, INC., BARCL Exhibit 10.1 FOURTH AMENDMENT to CREDIT AGREEMENT dated as of August 12, 2025 among MOLINA HEALTHCARE, INC., as the Borrower, THE LENDERS FROM TIME TO TIME PARTY HERETO, TRUIST BANK, as Administrative Agent, Swingline Lender and Issuing Bank TRUIST SECURITIES, INC., BARCLAYS BANK PLC, BOFA SECURITIES, N.A., DEUTSCHE BANK SECURITIES INC., GOLDMAN SACHS LENDER PARTNERS LLC, JPMORGAN CHASE BANK N.A.,
July 24, 2025	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 00
July 23, 2025	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 23, 2025 MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 1-31719 13-4204626 (State or other jurisdiction of incorporation) (Commission Fil
July 23, 2025	EX-99.1	Molina Healthcare Reports Second Quarter 2025 Financial Results Revises Full Year 2025 Guidance News Release Investor Contact: Jeffrey Geyer, [email protected], 305-317-3012 Media Contact: Caroline Zubieta, [email protected], 562-951-1588 Molina Healthcare Reports Second Quarter 2025 Financial Results Revises Full Year 2025 Guidance Long Beach, Calif, July 23, 2025 – Molina Healthcare, Inc. (NYSE: MOH) (the “Company”) today reported second quarter 2025 GA
July 7, 2025	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 7, 2025 MOLINA HEALTHCARE, I UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 7, 2025 MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 1-31719 13-4204626 (State or other jurisdiction of incorporation) (Commission File
July 7, 2025	EX-99.1	Molina Healthcare Announces Preliminary Second Quarter Financial Results and Updates Fiscal Year 2025 Earnings Per Share Guidance Exhibit 99.1 News Release Investor Contact: Jeffrey Geyer, [email protected], 305-317-3012 Media Contact: Caroline Zubieta, [email protected], 562-951-1588 Molina Healthcare Announces Preliminary Second Quarter Financial Results and Updates Fiscal Year 2025 Earnings Per Share Guidance Long Beach, Calif., July 7, 2025 – Molina Healthcare, Inc. (NYSE: MOH) today
May 1, 2025	EX-FILING FEES	Filing Fee Table Calculation of Filing Fee Tables S-8 MOLINA HEALTHCARE, INC. Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee 1 Equity Common stock, $0.001 par value per share 457(a) 2,811,729 $ 308.67 $ 867,896,390.43 0.0001531 $ 132,874.94 To
May 1, 2025	S-8	As filed with the Securities and Exchange Commission on May 1, 2025 As filed with the Securities and Exchange Commission on May 1, 2025 Registration No.
May 1, 2025	EX-10.1	Molina Healthcare, Inc. 2025 Equity Incentive Plan Molina Healthcare, Inc. 2025 Equity Incentive Plan Effective as of April 30, 2025 1.ESTABLISHMENT, PURPOSE AND TERM OF PLAN. 1.1 Establishment. Molina Healthcare, Inc. previously adopted the Molina Healthcare, Inc. 2019 Equity Incentive Plan (the “2019 Plan”). The 2019 Plan is hereby amended, restated, and merged into the Molina Healthcare, Inc. 2025 Equity Incentive Plan (the “Plan”) effective as
May 1, 2025	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 30, 2025 MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 1-31719 13-4204626 (State or other jurisdiction of incorporation) (Commission Fi
April 24, 2025	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 0
April 24, 2025	EX-10.1	Molina Healthcare, Inc. 2019 Equity Incentive Plan (As Amended 2025) 1 #695970v2 Molina Healthcare, Inc. 2019 Equity Incentive Plan Effective as of May 8, 2019 1. ESTABLISHMENT, PURPOSE AND TERM OF PLAN. 1.1 Establishment. Molina Healthcare, Inc. previously adopted the Molina Healthcare, Inc. 2011 Equity Incentive Plan (the “2011 Plan”), most recently amended and restated as of January 1, 2017. The 2011 Plan is hereby amended, restated, and merged into the Molina H
April 23, 2025	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 23, 2025 MOLINA HEALTHCARE, UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 23, 2025 MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 1-31719 13-4204626 (State or other jurisdiction of incorporation) (Commission Fi
April 23, 2025	EX-99.1	Molina Healthcare Reports First Quarter 2025 Financial Results Reaffirms Full Year 2025 Guidance News Release Investor Contact: Jeffrey Geyer, [email protected], 305-317-3012 Media Contact: Caroline Zubieta, [email protected], 562-951-1588 Molina Healthcare Reports First Quarter 2025 Financial Results Reaffirms Full Year 2025 Guidance Long Beach, Calif, April 23, 2025 – Molina Healthcare, Inc. (NYSE: MOH) (the “Company”) today reported first quarter 2025 G
March 18, 2025	EX-99.1	Molina Healthcare Wins Illinois Contract to Provide a Dual Eligible Special Needs Plan Exhibit 99.1 NEWS RELEASE Investor Contact: Jeff Geyer, [email protected], 305-317-3012 Media Contact: Caroline Zubieta, [email protected], 562-951-1588 Molina Healthcare Wins Illinois Contract to Provide a Dual Eligible Special Needs Plan LONG BEACH, Calif., Mar. 18, 2025 – Molina Healthcare, Inc. (NYSE: MOH) (“Molina” or the “Company”) announced today that th
March 18, 2025	8-K	Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 18, 2025 MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 1-31719 13-4204626 (State or other jurisdiction of incorporation) (Commission Fi
March 17, 2025	DEFA14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ___) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant þ Filed by a Party other than the Registrant ¨ Check the appropriate box: ú Preliminary Proxy Statement ú Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)
March 17, 2025	ARS	ARS Company Profile Molina Healthcare, Inc., a FORTUNE 500 company, provides managed healthcare services under the Medicaid and Medicare programs and through the state insurance marketplaces. Molina Healthcare served approximately 5.5 million members as of December 31, 2024. For more information about Molina Healthcare, please visit molinahealthcare.com. Line of Business Profile Membership by Line of
March 17, 2025	DEF 14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ___) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant þ Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)
February 21, 2025	EX-10.1	Third Amendment to Credit Agreement, dated as of February 19, 2025, by and among the Company, the Lenders party thereto and Truist Bank, as Administrative Agent, Issuing Bank and Swingline Lender Exhibit 10.1 THIRD AMENDMENT to CREDIT AGREEMENT dated as of February 19, 2025 among MOLINA HEALTHCARE, INC., as the Borrower, THE LENDERS FROM TIME TO TIME PARTY HERETO, TRUIST BANK, as Administrative Agent, Swingline Lender and Issuing Bank TRUIST SECURITIES, INC., as Lead Arranger and Bookrunner 1 THIRD AMENDMENT TO CREDIT AGREEMENT THIS THIRD AMENDMENT TO CREDIT AGREEMENT, dated as of February
February 21, 2025	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 19, 2025 MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 1-31719 13-4204626 (State or other jurisdiction of incorporation) (Commission
February 11, 2025	EX-4.7	Description of Registrant’s Securities DESCRIPTION OF THE REGISTRANT’S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 The Common Stock of Molina Healthcare, Inc.
February 11, 2025	EX-10.5	Molina Healthcare, Inc. 2019 Equity Incentive Plan {00404251;1} 1 Molina Healthcare, Inc. 2019 Equity Incentive Plan Effective as of May 8, 2019 1. ESTABLISHMENT, PURPOSE AND TERM OF PLAN. 1.1 Establishment. Molina Healthcare, Inc. previously adopted the Molina Healthcare, Inc. 2011 Equity Incentive Plan (the “2011 Plan”), most recently amended and restated as of January 1, 2017. The 2011 Plan is hereby amended, restated, and merged into the Molin
February 11, 2025	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number 1-31719 MOLINA HEALTHCARE
February 11, 2025	EX-21.1	List of Subsidiaries EXHIBIT 21.1 LIST OF SUBSIDIARIES Name Jurisdiction of Incorporation 2028 West Broadway, LLC Delaware Central Health Plan of California, Inc. California ConnectiCare Holding Company, Inc. Connecticut ConnectiCare Capital, LLC++++++ Connecticut ConnectiCare, Inc.+++++++ Connecticut ConnectiCare Insurance Company, Inc.+++++++ Connecticut ConnectiCare Benefits, Inc.++++++++** Connecticut MHAZ
February 5, 2025	EX-99.1	Molina Healthcare Reports Fourth Quarter and Year-End 2024 Financial Results Introduces Full Year 2025 Revenue and Earnings Guidance News Release Investor Contact: Jeffrey Geyer, [email protected], 305-317-3012 Media Contact: Caroline Zubieta, [email protected], 562-951-1588 Molina Healthcare Reports Fourth Quarter and Year-End 2024 Financial Results Introduces Full Year 2025 Revenue and Earnings Guidance Long Beach, Calif, February 5, 2025 – Molina Healthcare, Inc. (NYSE: MOH) (the “Company
February 5, 2025	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 5, 2025 MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 1-31719 13-4204626 (State or other jurisdiction of incorporation) (Commission
February 3, 2025	EX-99.1	Molina Healthcare Announces the Closing of its Acquisition of ConnectiCare Exhibit 99.1 News Release Investor Contact: Jeffrey Geyer, [email protected], 305-317-3012 Media Contact: Caroline Zubieta, [email protected], 562-951-1588 Molina Healthcare Announces the Closing of its Acquisition of ConnectiCare Long Beach, Calif., Feb. 3, 2025 – Molina Healthcare, Inc. (NYSE: MOH) today announced that its acquisition of ConnectiCare Holding
February 3, 2025	8-K	Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 3, 2025 MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 1-31719 13-4204626 (State or other jurisdiction of incorporation) (Commission
December 16, 2024	EX-99.1	Molina Healthcare Awarded Contracts to Serve Dual Eligible Populations in Michigan and Idaho Exhibit 99.1 NEWS RELEASE Investor Contact: Jeff Geyer, [email protected], 305-317-3012 Media Contact: Caroline Zubieta, [email protected], 562-951-1588 Molina Healthcare Awarded Contracts to Serve Dual Eligible Populations in Michigan and Idaho LONG BEACH, Calif., Dec. 16, 2024 – Molina Healthcare, Inc. (NYSE: MOH) (“Molina” or the “Company”) announced today t
December 16, 2024	8-K	Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 16, 2024 MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 1-31719 13-4204626 (State or other jurisdiction of incorporation) (Commission
November 18, 2024	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 18, 2024 MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-31719 13-4204626 (State or other jurisdiction of incorporation) (Commissi
November 18, 2024	EX-99.1	Molina Healthcare Announces Closing of Offering of $750 Million of 6.250% Senior Notes Due 2033 Exhibit 99.1 News Release Investor Contact: Jeff Geyer, [email protected], 305-317-3012 Media Contact: Caroline Zubieta, [email protected], 562-951-1588 Molina Healthcare Announces Closing of Offering of $750 Million of 6.250% Senior Notes Due 2033 Long Beach, Calif., November 18, 2024 – Molina Healthcare, Inc. (NYSE: MOH) (the “Company”) today announced the cl
November 18, 2024	EX-4.1	Indenture, dated as of November 18, 2024, by and between Molina Healthcare, Inc. and U.S. Bank Company Trust Company, National Association, as Trustee Exhibit 4.1 MOLINA HEALTHCARE, INC. $750,000,000 6.250% Senior Notes due 2033 INDENTURE Dated as of November 18, 2024 U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION as Trustee TABLE OF CONTENTS Page ARTICLE 1 DEFINITIONS AND INCORPORATION BY REFERENCE 1 Section 1.01 Definitions 1 Section 1.02 Other Definitions 14 Section 1.03 Incorporation by Reference of Trust Indenture Act 15 Section 1.04 Rules o
November 14, 2024	SC 13G/A	MOH / Molina Healthcare, Inc. / PRICE T ROWE ASSOCIATES INC /MD/ Passive Investment SC 13G/A 1 moh13gasep24.txt UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1) MOLINA HEALTHCARE INC (Name of Issuer) COMMON STOCK (Title of Class of Securities) 60855R100 (CUSIP NUMBER) September 30, 2024 (Date of Event which Requires Filing of Statement) Check the appropriate box to designate the Rule p
November 13, 2024	8-K	Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 13, 2024 MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-31719 13-4204626 (State or other jurisdiction of incorporation) (Commissi
November 13, 2024	EX-99.1	Molina Healthcare Announces Pricing of $750 Million of 6.250% Senior Notes Due 2033 EX-99.1 2 ex747620.htm EXHIBIT 99.1 Exhibit 99.1 News Release Investor Contact: Jeff Geyer, [email protected], 305-317-3012 Media Contact: Caroline Zubieta, [email protected], 562-951-1588 Molina Healthcare Announces Pricing of $750 Million of 6.250% Senior Notes Due 2033 Long Beach, Calif., November 13, 2024 – Molina Healthcare, Inc. (NYSE: MOH) (the “Company”
November 13, 2024	EX-99.1	Molina Healthcare Announces Proposed Offering of $500 Million of Senior Notes Due 2033 Exhibit 99.1 News Release Investor Contact: Jeff Geyer, [email protected], 305-317-3012 Media Contact: Caroline Zubieta, [email protected], 562-951-1588 Molina Healthcare Announces Proposed Offering of $500 Million of Senior Notes Due 2033 Long Beach, Calif., November 13, 2024 – Molina Healthcare, Inc. (NYSE: MOH) (the “Company”) today announced that it intends
November 13, 2024	8-K	Regulation FD Disclosure, Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 13, 2024 MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-31719 13-4204626 (State or other jurisdiction of incorporation) (Commissi
November 12, 2024	SC 13G	MOH / Molina Healthcare, Inc. / Capital Research Global Investors - SEC SCHEDULE 13G Passive Investment SC 13G 1 SEC13GFiling.htm SEC SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Molina Healthcare, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 60855R100 (CUSIP Number) September 30, 2024 (Date of Event Which Requires Filing of this Statement) Check the appropriate box t
November 12, 2024	8-K	Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 12, 2024 MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 1-31719 13-4204626 (State or other jurisdiction of incorporation) (Commission
November 8, 2024	SC 13G/A	MOH / Molina Healthcare, Inc. / WELLINGTON MANAGEMENT GROUP LLP - SEC SCHEDULE 13G Passive Investment SC 13G/A 1 SEC13GFiling.htm SEC SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1 )* Molina Healthcare, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 60855R100 (CUSIP Number) September 30, 2024 (Date of Event Which Requires Filing of this Statement) Check the appropriate b
November 8, 2024	EX-99.1	Molina Healthcare, Inc. 2024 Investor Day Presentation, dated November 8, 2024. Exhibit 99.1
November 8, 2024	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 8, 2024 MOLINA HEALTHCAR UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 8, 2024 MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 1-31719 13-4204626 (State or other jurisdiction of incorporation) (Commission
November 8, 2024	EX-99	JOINT FILING AGREEMENT JOINT FILING AGREEMENT The undersigned hereby agree that this Schedule 13G (the “Schedule 13G”) with respect to the common stock of Molina Healthcare, Inc.
October 24, 2024	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file numbe
October 23, 2024	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 23, 2024 MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 1-31719 13-4204626 (State or other jurisdiction of incorporation) (Commission
October 23, 2024	EX-99.1	Molina Healthcare Reports Third Quarter 2024 Financial Results Reaffirms Full Year 2024 Earnings Guidance News Release Investor Contact: Jeffrey Geyer, [email protected], 305-317-3012 Media Contact: Caroline Zubieta, [email protected], 562-951-1588 Molina Healthcare Reports Third Quarter 2024 Financial Results Reaffirms Full Year 2024 Earnings Guidance Long Beach, Calif, October 23, 2024 – Molina Healthcare, Inc. (NYSE: MOH) (the “Company”) today reported third qua
October 17, 2024	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 17, 2024 (October 16, 2024) MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 1-31719 13-4204626 (State or other jurisdiction of incorpor
October 17, 2024	EX-10.1	Performance Stock Unit Agreement, dated as of October 16, 2024. Exhibit 10.1 MOLINA HEALTHCARE, INC. 2019 EQUITY INCENTIVE PLAN PERFORMANCE STOCK UNIT AWARD AGREEMENT THIS PERFORMANCE STOCK UNIT AWARD AGREEMENT (together with the Terms (as defined below) and Exhibit A hereto, this “Agreement”) dated October 16, 2024, by and between MOLINA HEALTHCARE, INC., a Delaware corporation (the “Corporation”), and Mark L. Keim (the “Participant”), evidences the award of
October 16, 2024	8-K	Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 16, 2024 MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 1-31719 13-4204626 (State or other jurisdiction of incorporation) (Commission
October 16, 2024	EX-99.1	Molina Healthcare Wins Michigan Contract to Provide a New Dual Eligible Benefit Program Exhibit 99.1 NEWS RELEASE Investor Contact: Jeff Geyer, [email protected], 305-317-3012 Media Contact: Caroline Zubieta, [email protected], 562-951-1588 Molina Healthcare Wins Michigan Contract to Provide a New Dual Eligible Benefit Program LONG BEACH, Calif., Oct. 16, 2024 – Molina Healthcare, Inc. (NYSE: MOH) (“Molina” or the “Company”) announced today that t
September 23, 2024	EX-10.1	Second Amendment to Credit Agreement, dated as of September 20, 2024, by and among the Company, the Lenders party thereto and Truist Bank, as Administrative Agent, Issuing Bank and Swingline Lender. Exhibit 10.1 SECOND AMENDMENT to CREDIT AGREEMENT dated as of September 20, 2024 among MOLINA HEALTHCARE, INC., as the Borrower, THE LENDERS FROM TIME TO TIME PARTY HERETO, TRUIST BANK, as Administrative Agent, Swingline Lender and Issuing Bank TRUIST SECURITIES, INC. BARCLAYS BANK PLC BOFA SECURITIES, INC. DEUTSCHE BANK SECURITIES INC. GOLDMAN SACHS LENDING PARTNERS LLC JPMORGAN CHASE BANK, N.A.
September 23, 2024	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 23, 2024 (September 20, 2024) MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 1-31719 13-4204626 (State or other jurisdiction of inco
August 20, 2024	EX-10.2	Performance Stock Unit Agreement, dated as of August 19, 2024. Exhibit 10.2 MOLINA HEALTHCARE, INC. 2019 EQUITY INCENTIVE PLAN PERFORMANCE STOCK UNIT AWARD AGREEMENT THIS PERFORMANCE STOCK UNIT AWARD AGREEMENT (together with the Terms (as defined below) and Exhibit A hereto, this “Agreement”) dated August 19, 2024, by and between MOLINA HEALTHCARE, INC., a Delaware corporation (the “Corporation”), and Joseph M. Zubretsky (the “Participant”), evidences the awa
August 20, 2024	EX-10.1	Amendment of Employment Agreement, dated August 19, 2024, by and between Molina Healthcare, Inc. and Joseph M. Zubretsky Exhibit 10.1 AMENDMENT OF EMPLOYMENT AGREEMENT This Amendment of Employment Agreement is entered into as of August 19, 2024, by and between Joseph M. Zubretsky (the “Executive”) and Molina Healthcare, Inc. (the “Employer”). WHEREAS, the parties entered into that certain Amended and Restated Employment Agreement dated as of September 8, 2021, as amended on February 16, 2022 (the “Agreement”); and W
August 20, 2024	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 20, 2024 (August 19, 2024) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 20, 2024 (August 19, 2024) MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 1-31719 13-4204626 (State or other jurisdiction of incorporat
July 25, 2024	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 00
July 24, 2024	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 24, 2024 MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 1-31719 13-4204626 (State or other jurisdiction of incorporation) (Commission Fil
July 24, 2024	EX-99.1	Molina Healthcare Reports Second Quarter 2024 Financial Results Reaffirms Full Year 2024 Earnings Guidance News Release Investor Contact: Jeffrey Geyer, [email protected], 305-317-3012 Media Contact: Caroline Zubieta, [email protected], 562-951-1588 Molina Healthcare Reports Second Quarter 2024 Financial Results Reaffirms Full Year 2024 Earnings Guidance Long Beach, Calif, July 24, 2024 – Molina Healthcare, Inc. (NYSE: MOH) (the “Company”) today reported second quar
May 3, 2024	8-K	Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 1, 2024 MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 1-31719 13-4204626 (State or other jurisdiction of incorporation) (Commission File
April 25, 2024	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 0
April 24, 2024	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 24, 2024 MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 1-31719 13-4204626 (State or other jurisdiction of incorporation) (Commission Fi
April 24, 2024	EX-99.1	Molina Healthcare Reports First Quarter 2024 Financial Results Reaffirms Full Year 2024 Guidance News Release Investor Contact: Jeffrey Geyer, [email protected], 305-317-3012 Media Contact: Caroline Zubieta, [email protected], 562-951-1588 Molina Healthcare Reports First Quarter 2024 Financial Results Reaffirms Full Year 2024 Guidance Long Beach, Calif, April 24, 2024 – Molina Healthcare, Inc. (NYSE: MOH) (the “Company”) today reported first quarter 2024 G
April 11, 2024	8-K	Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 11, 2024 (April 8, 2024) MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 1-31719 13-4204626 (State or other jurisdiction of incorporation
April 11, 2024	EX-99.1	Molina Healthcare Wins Michigan Medicaid Contract Exhibit 99.1 NEWS RELEASE Investor Contact: Jeff Geyer, [email protected], 305-317-3012 Media Contact: Caroline Zubieta, [email protected], 562-951-1588 Molina Healthcare Wins Michigan Medicaid Contract LONG BEACH, Calif., Apr. 11, 2024 – Molina Healthcare, Inc. (NYSE: MOH) (“Molina” or the “Company”) announced today that the Michigan Department of Health and H
March 21, 2024	DEFA14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ___) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant þ Filed by a Party other than the Registrant ¨ Check the appropriate box: ú Preliminary Proxy Statement ú Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)
March 21, 2024	ARS	ARS Company Profile Molina Healthcare, Inc., a FORTUNE 500 company, provides managed healthcare services under the Medicaid and Medicare programs and through the state insurance marketplaces. Molina Healthcare served approximately 5.0 million members as of December 31, 2023. For more information about Molina Healthcare, please visit molinahealthcare.com. Line of Business Profile Membership by Line of
March 21, 2024	DEF 14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ___) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant þ Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)
February 29, 2024	EX-99.1	Molina Healthcare Provides Update on the Virginia Cardinal Care Managed Care Contract Exhibit 99.1 News Release Investor Contact: Jeffrey Geyer, [email protected], 305-317-3012 Media Contact: Caroline Zubieta, [email protected], 562-951-1588 Molina Healthcare Provides Update on the Virginia Cardinal Care Managed Care Contract LONG BEACH, Calif., Feb. 29, 2024 – Molina Healthcare, Inc. (NYSE: MOH) (“Molina” or the “Company”) announced today that
February 29, 2024	8-K	Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 29, 2024 MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 1-31719 13-4204626 (State or other jurisdiction of incorporation) (Commission
February 14, 2024	SC 13G	MOH / Molina Healthcare, Inc. / PRICE T ROWE ASSOCIATES INC /MD/ Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. ) MOLINA HEALTHCARE INC (Name of Issuer) COMMON STOCK (Title of Class of Securities) 60855R100 (CUSIP NUMBER) December 31, 2023 (Date of Event which Requires Filing of Statement) Check the appropriate box to designate the Rule pursuant to which this Schedule
February 13, 2024	EX-97	Molina Healthcare, Inc. Policy for Recovery of Erroneously Awarded Compensation #606562v4 MOLINA HEALTHCARE, INC. POLICY FOR RECOVERY OF ERRONEOUSLY AWARDED COMPENSATION Molina Healthcare, Inc. (the “Company”) has adopted this Policy for Recovery of Erroneously Awarded Compensation (the “Policy”), effective as of October 2, 2023 (the “Effective Date”). Capitalized terms used in this Policy but not otherwise defined in the text of this Policy are defined in Section 11. Except
February 13, 2024	EX-10.4	Molina Healthcare, Inc. 2019 Equity Incentive Plan {00404251;1} 1 Molina Healthcare, Inc. 2019 Equity Incentive Plan Effective as of May 8, 2019 1. ESTABLISHMENT, PURPOSE AND TERM OF PLAN. 1.1 Establishment. Molina Healthcare, Inc. previously adopted the Molina Healthcare, Inc. 2011 Equity Incentive Plan (the “2011 Plan”), most recently amended and restated as of January 1, 2017. The 2011 Plan is hereby amended, restated, and merged into the Molin
February 13, 2024	SC 13G/A	MOH / Molina Healthcare, Inc. / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SC 13G/A 1 tv01476-molinahealthcareinc.htm SCHEDULE 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 10)* Name of issuer: Molina Healthcare Inc Title of Class of Securities: Common Stock CUSIP Number: 60855R100 Date of Event Which Requires Filing of this Statement: December 29, 2023 Check the appropriate box to d
February 13, 2024	EX-21.1	List of Subsidiaries EXHIBIT 21.1 LIST OF SUBSIDIARIES Name Jurisdiction of Incorporation 2028 West Broadway, LLC Delaware Central Health Plan of California, Inc. ++++++ California MHAZ, Inc.* Arizona Molina Healthcare Data Center, LLC New Mexico Molina Healthcare of Arizona, Inc. Arizona Molina Healthcare of California California Molina Healthcare of Florida, Inc. Florida Molina Healthcare of Georgia, Inc.* Georgia M
February 13, 2024	EX-3.2	Certificate of Amendment to Certificate of Incorporation Jeffrey mBulloa,secmtary astate AUTHEN TION: 0404163 DATE: 05-02-13 Delaware PAGE I The First State I, JEFFREY W.
February 13, 2024	EX-3.3	Certificate of Amendment to Certificate of Incorporation Delaware The First State Page 1 3551135 8100 Authentication: 202800933 SR# 20193729983 Date: 05-10-19 You may verify this certificate online at corp.
February 13, 2024	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number 1-31719 MOLINA HEALTHCARE
February 13, 2024	EX-10.3	2019 Employee Stock Purchase Plan Table of Contents Appendix C - 1 MOLINA HEALTHCARE, INC. 2019 EMPLOYEE STOCK PURCHASE PLAN EFFECTIVE MAY 8, 2019 1. Establishment of Plan. Molina Healthcare, Inc., a Delaware corporation (the “Company”), previously adopted the Molina Healthcare, Inc. 2011 Employee Stock Purchase Plan (the “2011 Plan”), most recently amended as of July 26, 2016, to grant options to purchase shares of the Company’s
February 9, 2024	SC 13G/A	MOH / Molina Healthcare, Inc. / Capital World Investors - SEC SCHEDULE 13G Passive Investment SC 13G/A 1 SEC13GFiling.htm SEC SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 12 )* Molina Healthcare, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 60855R100 (CUSIP Number) December 29, 2023 (Date of Event Which Requires Filing of this Statement) Check the appropriate b
February 9, 2024	SC 13G/A	MOH / Molina Healthcare, Inc. / FMR LLC Passive Investment SCHEDULE 13G Amendment No.1 MOLINA HEALTHCARE INC COMMON STOCK Cusip #60855R100 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [x] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) Cusip #60855R100 Item 1: Reporting Person - FMR LLC Item 2: (a) [ ] (b) [ ] Item 4: Delaware Item 5: 1,944,966 Item 6: 0 Item 7: 1,977,222 Item 8: 0 Item 9: 1,977,222 Item 11:
February 8, 2024	SC 13G	MOH / Molina Healthcare, Inc. / WELLINGTON MANAGEMENT GROUP LLP - SEC SCHEDULE 13G Passive Investment SC 13G 1 SEC13GFiling.htm SEC SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* MOLINA HEALTHCARE, INC. (Name of Issuer) Common Stock (Title of Class of Securities) 60855R100 (CUSIP Number) December 29, 2023 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to
February 7, 2024	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 7, 2024 MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 1-31719 13-4204626 (State or other jurisdiction of incorporation) (Commission
February 7, 2024	EX-99.1	Molina Healthcare Reports Fourth Quarter and Year-End 2023 Financial Results Introduces Full Year 2024 Revenue and Earnings Guidance News Release Investor Contact: Joseph Krocheski, [email protected], 562-549-4100 Media Contact: Caroline Zubieta, [email protected], 562-951-1588 Molina Healthcare Reports Fourth Quarter and Year-End 2023 Financial Results Introduces Full Year 2024 Revenue and Earnings Guidance Long Beach, Calif, February 7, 2024 – Molina Healthcare, Inc. (NYSE: MOH) (the “C
January 25, 2024	SC 13G/A	MOH / Molina Healthcare, Inc. / BlackRock Inc. Passive Investment SC 13G/A 1 us60855r1005012524.txt us60855r1005012524.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 11) MOLINA HEALTHCARE INC - (Name of Issuer) Common Stock - (Title of Class of Securities) 60855R100 - (CUSIP Number) December 31, 2023 - (Date of Event Which Requires Filing of this Statement) Check the appropriate
January 2, 2024	EX-99.1	Molina Healthcare Announces the Closing of its Acquisition of Bright Healthcare’s California Medicare Business Exhibit 99.1 Molina Healthcare Announces the Closing of its Acquisition of Bright Healthcare’s California Medicare Business LONG BEACH, Calif.-(BUSINESS WIRE)-January 2, 2024-Molina Healthcare, Inc. (NYSE: MOH) today announced that its acquisition of Bright Healthcare’s California Medicare business closed effective as of January 1, 2024. At closing, Bright Healthcare’s California Medicare business
January 2, 2024	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 2, 2024 (January 2, 2024) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 2, 2024 (January 2, 2024) MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-31719 13-4204626 (State or other jurisdiction of incorpor
December 26, 2023	EX-3.1	Amended and Restated Bylaws of Molina Healthcare, Inc. molinahealthcare-amended AMENDED AND RESTATED BYLAWS OF MOLINA HEALTHCARE, INC. a Delaware corporation (as Amended and Restated Effective December 22, 2023) i TABLE OF CONTENTS Page ARTICLE I OFFICES .....................................................................................................................1 Section 1.1 Registered Office....................................................
December 26, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 26, 2023 (December 22, 2 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 26, 2023 (December 22, 2023) MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 1-31719 13-4204626 (State or other jurisdiction of incorp
December 18, 2023	EX-99.1	Molina Healthcare Amends Terms for Acquisition of Bright HealthCare’s California Medicare Business Exhibit 99.1 Molina Healthcare Amends Terms for Acquisition of Bright HealthCare’s California Medicare Business Expected closing on or about January 1, 2024 LONG BEACH, Calif.-(BUSINESS WIRE)-December 18, 2023-Molina Healthcare, Inc. (NYSE: MOH) (“Molina” or the “Company”) announced today that on December 13, 2023, the Company amended its purchase agreement for the acquisition of Bright HealthCare
December 18, 2023	8-K	Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 18, 2023 (December 18, 2023) MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-31719 13-4204626 (State or other jurisdiction of inco
October 26, 2023	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file numbe
October 26, 2023	EX-10.1	First Amendment to Molina Healthcare, Inc. Amended and Restated Deferred Compensation Plan (2022) AMENDMENT NO. ONE TO THE MOLINA HEALTHCARE, INC. AMENDED AND RESTATED DEFERRED COMPENSATION PLAN (2022) Section 7 of the Molina Healthcare, Inc. Amended and Restated Deferred Compensation Plan (2022) effective for amounts earned and deferred on or after January 1, 2022 (the “Plan”) allows Molina Healthcare, Inc. (the “Company”) to amend the terms of the Plan, at any time by resolution of the Plan
October 25, 2023	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 25, 2023 MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 1-31719 13-4204626 (State or other jurisdiction of incorporation) (Commission
October 25, 2023	EX-99.1	Molina Healthcare Reports Third Quarter 2023 Financial Results Affirms Full Year 2023 Earnings Guidance News Release Investor Contact: Joseph Krocheski, [email protected], 562-549-4100 Media Contact: Caroline Zubieta, [email protected], 562-951-1588 Molina Healthcare Reports Third Quarter 2023 Financial Results Affirms Full Year 2023 Earnings Guidance Long Beach, Calif, October 25, 2023 – Molina Healthcare, Inc. (NYSE: MOH) (the “Company”) today reported third
October 2, 2023	8-K	Regulation FD Disclosure UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 2, 2023 (September 27, 2023) MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-31719 13-4204626 (State or other jurisdiction of incor
September 5, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 5, 2023 (September 1, 2 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 5, 2023 (September 1, 2023) MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-31719 13-4204626 (State or other jurisdiction of inco
September 5, 2023	EX-99.1	Molina Healthcare Announces the Closing of its Acquisition of My Choice Wisconsin Exhibit 99.1 Molina Healthcare Announces the Closing of its Acquisition of My Choice Wisconsin LONG BEACH, Calif.-(BUSINESS WIRE)-September 5, 2023-Molina Healthcare, Inc. (NYSE: MOH) today announced that its acquisition of My Choice Wisconsin (“MCW”) closed on September 1, 2023. As of June 30, 2023, MCW served over 44,000 members. About Molina Healthcare Molina Healthcare, Inc., a FORTUNE 500 com
August 14, 2023	8-K	Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 14, 2023 (August 14, 2023) MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-31719 13-4204626 (State or other jurisdiction of incorpor
August 14, 2023	EX-99.1	Molina Healthcare of New Mexico Receives Notification of Intent to Award New Medicaid Contract Exhibit 99.1 Molina Healthcare of New Mexico Receives Notification of Intent to Award New Medicaid Contract LONG BEACH, Calif.-(BUSINESS WIRE)-August 14, 2023-Molina Healthcare, Inc. (NYSE: MOH) (“Molina” or the “Company”) confirmed that the New Mexico Human Services Department (HSD) has announced its intention to award a Medicaid managed care contract to Molina’s New Mexico health plan, Molina He
August 11, 2023	8-K/A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 11, 2023 (May 3, 2023) M UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 11, 2023 (May 3, 2023) MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 1-31719 13-4204626 (State or other jurisdiction of incorporatio
July 27, 2023	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 00
July 26, 2023	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 26, 2023 (July 26, 2023) MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 1-31719 13-4204626 (State or other jurisdiction of incorporation)
July 26, 2023	EX-99.1	Molina Healthcare Reports Second Quarter 2023 Financial Results Increases Full-Year 2023 Earnings Guidance News Release Investor Contact: Joseph Krocheski, [email protected], 562-549-4100 Media Contact: Caroline Zubieta, [email protected], 562-951-1588 Molina Healthcare Reports Second Quarter 2023 Financial Results Increases Full-Year 2023 Earnings Guidance Long Beach, Calif, July 26, 2023 – Molina Healthcare, Inc. (NYSE: MOH) (the “Company”) today reported secon
June 30, 2023	EX-99.1	Molina Healthcare to Acquire Bright HealthCare’s California Medicare Business Exhibit 99.1 Molina Healthcare to Acquire Bright HealthCare’s California Medicare Business Transaction expands Molina’s Medicare presence in California and is expected to add $1.00 per share to new store embedded earnings1 LONG BEACH, Calif.-(BUSINESS WIRE)-June 30, 2023-Molina Healthcare, Inc. (NYSE: MOH) (“Molina” or the “Company”) announced today that it has entered into a definitive agreement
June 30, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 30, 2023 (June 30, 2023) MOL UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 30, 2023 (June 30, 2023) MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-31719 13-4204626 (State or other jurisdiction of incorporatio
May 16, 2023	EX-99.1	Molina Healthcare Announces Promotions of Two Senior Executives Exhibit 99.1 Molina Healthcare Announces Promotions of Two Senior Executives LONG BEACH, Calif.-(BUSINESS WIRE)-May 16, 2023-Molina Healthcare, Inc. (NYSE: MOH) (“Molina”) today announced that Jim Woys and Mark Keim have each been promoted to the position of senior executive vice president, effective May 15th. With this promotion, Woys also assumes the role of chief operating officer. Keim will co
May 16, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 16, 2023 (May 15, 2023) MOLIN UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 16, 2023 (May 15, 2023) MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-31719 13-4204626 (State or other jurisdiction of incorporation)
May 16, 2023	EX-99.2	Investor Day 2023Sustaining Profitable Growth:The Next Wave May 15, 2023 Sustaining Profitable Growth: The Next Wave Topic Speaker Welcome and Introduction Joe Krocheski Sustaining Profitable Growth Joe Zubretsky Compelling Financial Profile Mark Kei Exhibit 99.2 Investor Day 2023Sustaining Profitable Growth:The Next Wave May 15, 2023 Sustaining Profitable Growth: The Next Wave Topic Speaker Welcome and Introduction Joe Krocheski Sustaining Profitable Growth Joe Zubretsky Compelling Financial Profile Mark Keim Executive Q&A Joe Zubretsky Mark Keim Cautionary Statement Safe Harbor Statement under the Private Securities Litigation Reform Act of
May 5, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 5, 2023 (May 3, 2023) MOLINA UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 5, 2023 (May 3, 2023) MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 1-31719 13-4204626 (State or other jurisdiction of incorporation) (Co
April 27, 2023	EX-10.1	First Amendment to Credit Agreement, dated as of April 26, 2023, by and between Molina Healthcare, Inc. and Truist Bank, in its capacity as Administrative Agent exhibit101firstamendmen 1312454.1 FIRST AMENDMENT TO CREDIT AGREEMENT THIS FIRST AMENDMENT TO CREDIT AGREEMENT, dated as of April 26, 2023 (this “Amendment”), is entered into between Molina Healthcare, Inc., a Delaware corporation (the “Borrower”), and Truist Bank, in its capacity as Administrative Agent (the “Administrative Agent”), effective as of the Effective Time (as defined below). Capitaliz
April 27, 2023	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 0
April 26, 2023	EX-99.1	Molina Healthcare Reports First Quarter 2023 Financial Results Increases Full-Year 2023 Earnings Guidance News Release Investor Contact: Joseph Krocheski, [email protected], 562-951-8382 Media Contact: Caroline Zubieta, [email protected], 562-951-1588 Molina Healthcare Reports First Quarter 2023 Financial Results Increases Full-Year 2023 Earnings Guidance Long Beach, Calif, April 26, 2023 – Molina Healthcare, Inc. (NYSE: MOH) (the “Company”) today reported first
April 26, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 26, 2023 (April 26, 2023) M UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 26, 2023 (April 26, 2023) MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 1-31719 13-4204626 (State or other jurisdiction of incorporatio
March 20, 2023	DEFA14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ___) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant þ Filed by a Party other than the Registrant ¨ Check the appropriate box: ú Preliminary Proxy Statement ú Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)
March 20, 2023	DEF 14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ___) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant þ Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)
March 6, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 6, 2023 (March 6, 2023) MOL UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 6, 2023 (March 6, 2023) MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-31719 13-4204626 (State or other jurisdiction of incorporatio
March 6, 2023	EX-99.1	Molina Healthcare of Indiana Recommended for MLTSS Award Exhibit 99.1 Molina Healthcare of Indiana Recommended for MLTSS Award LONG BEACH, Calif.-(BUSINESS WIRE)-March 6, 2023-Molina Healthcare, Inc. (NYSE: MOH) (“Molina”) today announced that the Indiana Department of Administration has recommended that contract negotiations begin with Molina’s Indiana health plan, Molina Healthcare of Indiana, Inc. Under the proposed contract with the Indiana Family a
February 14, 2023	SC 13G/A	MOH / Molina Healthcare, Inc. / PRICE T ROWE ASSOCIATES INC /MD/ Passive Investment SC 13G/A 1 moh13gadec22.txt UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 6) MOLINA HEALTHCARE INC (Name of Issuer) COMMON STOCK (Title of Class of Securities) 60855R100 (CUSIP NUMBER) December 31, 2022 (Date of Event which Requires Filing of Statement) Check the appropriate box to designate the Rule pu
February 13, 2023	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 1-31719 MOLINA HEALTHCARE, INC. (Exact name of registrant a
February 13, 2023	EX-21.1	List of Subsidiaries EXHIBIT 21.1 LIST OF SUBSIDIARIES Name Jurisdiction of Incorporation 2028 West Broadway, LLC Delaware MHAZ, Inc.* Arizona Molina Healthcare Data Center, LLC New Mexico Molina Healthcare of Arizona, Inc. Arizona Molina Healthcare of California California Molina Healthcare of Florida, Inc. Florida Molina Healthcare of Georgia, Inc.* Georgia Molina Healthcare of Illinois, Inc. Illinois Molina Healthc
February 13, 2023	SC 13G/A	MOH / Molina Healthcare, Inc. / Capital World Investors - SEC SCHEDULE 13G Passive Investment SC 13G/A 1 SEC13GFiling.htm SEC SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 11 )* Molina Healthcare, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 60855R100 (CUSIP Number) December 30, 2022 (Date of Event Which Requires Filing of this Statement) Check the appropriate b
February 9, 2023	SC 13G	MOH / Molina Healthcare, Inc. / FMR LLC Passive Investment SC 13G 1 filing.txt SCHEDULE 13G Amendment No.0 MOLINA HEALTHCARE INC COMMON STOCK Cusip #60855R100 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [x] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) Cusip #60855R100 Item 1: Reporting Person - FMR LLC Item 2: (a) [ ] (b) [ ] Item 4: Delaware Item 5: 3,570,953 Item 6: 0 Item 7: 3,592,411 Item 8: 0 Item 9:
February 9, 2023	SC 13G/A	MOH / Molina Healthcare, Inc. / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SC 13G/A 1 tv01443-molinahealthcareinc.htm SCHEDULE 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 9)* Name of issuer: Molina Healthcare Inc. Title of Class of Securities: Common Stock CUSIP Number: 60855R100 Date of Event Which Requires Filing of this Statement: December 30, 2022 Check the appropriate box to d
February 8, 2023	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 8, 2023 (February 8, 2023) MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 1-31719 13-4204626 (State or other jurisdiction of incorpor
February 8, 2023	EX-99.1	Molina Healthcare Reports Fourth Quarter and Year-End 2022 Financial Results Introduces Full-Year 2023 Revenue and Earnings Guidance EX-99.1 2 moh4q22er.htm EX-99.1 News Release Investor Contact: Joseph Krocheski, [email protected], 562-951-8382 Media Contact: Caroline Zubieta, [email protected], 562-951-1588 Molina Healthcare Reports Fourth Quarter and Year-End 2022 Financial Results Introduces Full-Year 2023 Revenue and Earnings Guidance Long Beach, Calif, February 8, 2023 – Molina Heal
February 6, 2023	SC 13G/A	MOH / Molina Healthcare, Inc. / WELLINGTON MANAGEMENT GROUP LLP - SEC SCHEDULE 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1 )* MOLINA HEALTHCARE, INC. (Name of Issuer) Common Stock (Title of Class of Securities) 60855R100 (CUSIP Number) December 30, 2022 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which thi
February 3, 2023	SC 13G/A	MOH / Molina Healthcare, Inc. / BlackRock Inc. Passive Investment us60855r1005020323.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 10) MOLINA HEALTHCARE INC - (Name of Issuer) Common Stock - (Title of Class of Securities) 60855R100 - (CUSIP Number) December 31, 2022 - (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuan
January 4, 2023	EX-99.1	Molina Healthcare Projects its California Medicaid Revenue will Double Under Revised Medi-Cal Contract Awards News Release Investor Contact: Joseph Krocheski, [email protected], 562-951-8382 Media Contact: Caroline Zubieta, [email protected], 562-951-1588 Molina Healthcare Projects its California Medicaid Revenue will Double Under Revised Medi-Cal Contract Awards LONG BEACH, Calif., January 3, 2023 ? Molina Healthcare, Inc. (NYSE: MOH) (?Molina?) confirmed today tha
January 4, 2023	8-K	Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 4, 2023 (January 3, 2023) MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 1-31719 13-4204626 (State or other jurisdiction of incorporat
December 30, 2022	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 30, 2022 (December 30, 2 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 30, 2022 (December 30, 2022) MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-31719 13-4204626 (State or other jurisdiction of inco
December 29, 2022	8-K	Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 29, 2022 (December 28, 2022) MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-31719 13-4204626 (State or other jurisdiction of inco
October 27, 2022	EX-10.1	Change Request #7 to the Master Services Agreement dated February 2, 2019, by and between Molina Healthcare, Inc. and Infosys Limited Pursuant to Item 601(b)(10) of Regulation S-K, portions of this exhibit have been excluded because the information is not material and is the type that the registrant treats as confidential.
October 27, 2022	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file numbe
October 26, 2022	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 26, 2022 (October 26, 2022) MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 1-31719 13-4204626 (State or other jurisdiction of incorpor
October 26, 2022	EX-99.1	Molina Healthcare Reports Third Quarter 2022 Financial Results Increases Full-Year 2022 Revenue and Earnings Guidance News Release Investor Contact: Joseph Krocheski, [email protected], 562-951-8382 Media Contact: Caroline Zubieta, [email protected], 562-951-1588 Molina Healthcare Reports Third Quarter 2022 Financial Results Increases Full-Year 2022 Revenue and Earnings Guidance Long Beach, Calif, October 26, 2022 ? Molina Healthcare, Inc. (NYSE: MOH) (the ?Company?) today
October 3, 2022	EX-99.1	Molina Healthcare Announces the Closing of its Acquisition of AgeWell New York’s Managed Long Term Care Plan Exhibit 99.1 Molina Healthcare Announces the Closing of its Acquisition of AgeWell New York?s Managed Long Term Care Plan LONG BEACH, Calif.-(BUSINESS WIRE)-October 3, 2022-Molina Healthcare, Inc. (NYSE: MOH) today announced that its acquisition of AgeWell New York?s Medicaid Managed Long Term Care (MLTC) business closed on October 1, 2022. As of September 30, 2022, AgeWell New York?s MLTC busines
October 3, 2022	8-K	Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 3, 2022 (October 1, 2022) MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-31719 13-4204626 (State or other jurisdiction of incorpor
September 26, 2022	EX-99.1	Molina Healthcare Selected For Nebraska Medicaid Managed Care Program Exhibit 99.1 Molina Healthcare Selected For Nebraska Medicaid Managed Care Program LONG BEACH, Calif.-(BUSINESS WIRE)-September 26, 2022-Molina Healthcare, Inc. (NYSE: MOH) (?Molina?) today announced that its health plan subsidiary, Molina Healthcare of Nebraska, has been selected by the Nebraska Department of Health and Human Services (DHHS) to provide health care services to Nebraskans under the
September 26, 2022	8-K	Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 26, 2022 (September 23, 2022) MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-31719 13-4204626 (State or other jurisdiction of in
August 31, 2022	8-K	Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 31, 2022 (August 31, 2022) MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-31719 13-4204626 (State or other jurisdiction of incorpor
August 31, 2022	EX-99.1	Molina Healthcare Wins Iowa Medicaid Contract Exhibit 99.1 Molina Healthcare Wins Iowa Medicaid Contract LONG BEACH, Calif.-(BUSINESS WIRE)-August 31, 2022-Molina Healthcare, Inc. (NYSE: MOH) (?Molina? or the ?Company?) confirmed that the Iowa Department of Health and Human Services (HHS) has announced its intent to award Molina?s Iowa health plan a Medicaid managed care contract pursuant to the Request for Proposal issued by HHS on February
August 29, 2022	8-K	Regulation FD Disclosure UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 29, 2022 (August 25, 2022) MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-31719 13-4204626 (State or other jurisdiction of incorpor
August 17, 2022	8-K	Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 17, 2022 (August 17, 2022) MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 1-31719 13-4204626 (State or other jurisdiction of incorporat
August 10, 2022	8-K	Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 10, 2022 (August 10, 2022) MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 1-31719 13-4204626 (State or other jurisdiction of incorporat
August 10, 2022	EX-99.1	Molina Healthcare Receives Notice of Intent to Award Mississippi Medicaid Contract NEWS RELEASE Investor Contact: Joseph Krocheski, [email protected], 562-951-8382 Media Contact: Caroline Zubieta, [email protected], 562-951-1588 Molina Healthcare Receives Notice of Intent to Award Mississippi Medicaid Contract LONG BEACH, Calif., Aug. 10, 2022 ? Molina Healthcare, Inc. (NYSE: MOH) (?Molina?) announced that its Mississippi health plan subsi
July 28, 2022	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 00
July 27, 2022	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 27, 2022 (July 27, 2022) MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 1-31719 13-4204626 (State or other jurisdiction of incorporation)
July 27, 2022	EX-99.1	Molina Healthcare Reports Second Quarter 2022 Financial Results Increases Full-Year 2022 Revenue and Earnings Guidance News Release Investor Contact: Joseph Krocheski, [email protected], 562-951-8382 Media Contact: Caroline Zubieta, [email protected], 562-951-1588 Molina Healthcare Reports Second Quarter 2022 Financial Results Increases Full-Year 2022 Revenue and Earnings Guidance Long Beach, Calif, July 27, 2022 ? Molina Healthcare, Inc. (NYSE: MOH) (the ?Company?) today re
July 13, 2022	8-K	Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 13, 2022 (July 13, 2022) MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-31719 13-4204626 (State or other jurisdiction of incorporatio
July 13, 2022	EX-99.1	Molina Healthcare to Acquire My Choice Wisconsin Exhibit 99.1 Molina Healthcare to Acquire My Choice Wisconsin Transaction Expands Molina?s Medicaid Managed Long-Term Care Presence into Wisconsin LONG BEACH, Calif.-(BUSINESS WIRE)-July 13, 2022-Molina Healthcare, Inc. (NYSE: MOH) (?Molina?) announced today that it has entered into a definitive agreement to acquire substantially all the assets of My Choice Wisconsin (?MCW?). The purchase price fo
May 6, 2022	8-K	Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 6, 2022 (May 4, 2022) MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 1-31719 13-4204626 (State or other jurisdiction of incorporation) (Co
April 28, 2022	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 0
April 27, 2022	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 27, 2022 (April 27, 2022) MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 1-31719 13-4204626 (State or other jurisdiction of incorporatio
April 27, 2022	EX-99.1	Molina Healthcare Reports First Quarter 2022 Financial Results Increases Full-Year 2022 Revenue and Earnings Guidance News Release Investor Contact: Joseph Krocheski, [email protected], 562-951-8382 Media Contact: Caroline Zubieta, [email protected], 562-951-1588 Molina Healthcare Reports First Quarter 2022 Financial Results Increases Full-Year 2022 Revenue and Earnings Guidance Long Beach, Calif, April 27, 2022 ? Molina Healthcare, Inc. (NYSE: MOH) (the ?Company?) today re
April 8, 2022	SC 13G/A	MOH / Molina Healthcare, Inc. / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 8)* Name of issuer: Molina Healthcare Inc. Title of Class of Securities: Common Stock CUSIP Number: 60855R100 Date of Event Which Requires Filing of this Statement: March 31, 2022 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ?
March 23, 2022	DEF 14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ___) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)
March 23, 2022	DEFA14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ___) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)
February 16, 2022	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 16, 2022 (February 16, 2022) MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 1-31719 13-4204626 (State or other jurisdiction of incorp
February 16, 2022	EX-10.1	Amendment of Employment Agreement, dated February 16, 2022, by and between Molina Healthcare, Inc. and Joseph M. Zubretsky Exhibit 10.1 AMENDMENT OF EMPLOYMENT AGREEMENT This Amendment of Employment Agreement is entered into as of February 16, 2022, by and between Joseph M. Zubretsky (the ?Executive?) and Molina Healthcare, Inc. (the ?Employer?). WHEREAS, the parties entered into that certain Amended and Restated Employment Agreement dated as of September 8, 2021 (the ?Agreement?); and WHEREAS, the parties desire to a
February 14, 2022	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2021 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 1-31719 MOLINA HEALTHCARE, INC. (Exact name of registrant a
February 14, 2022	SC 13G/A	MOH / Molina Healthcare, Inc. / PRICE T ROWE ASSOCIATES INC /MD/ Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 5) MOLINA HEALTHCARE, INC. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 60855R100 (CUSIP NUMBER) December 31, 2021 (Date of Event which Requires Filing of Statement) Check the appropriate box to designate the Rule pursuant to which this Sched
February 14, 2022	EX-10.10	Molina Healthcare, Inc. Amended and Restated Deferred Compensation Plan (2022) MOLINA HEALTHCARE, INC. AMENDED AND RESTATED DEFERRED COMPENSATION PLAN (2022) This Deferred Compensation Plan (the ?Plan?) is amended and restated effective for amounts earned and deferred on or after January 1, 2022 (the ?Restatement?), by MOLINA HEALTHCARE, INC., a Delaware corporation (the ?Company?) with reference to the following: A. The Company originally established a Deferred Compensation
February 14, 2022	EX-21.1	List of Subsidiaries EXHIBIT 21.1 LIST OF SUBSIDIARIES Name Jurisdiction of Incorporation 2028 West Broadway, LLC Delaware MHAZ, Inc.* Arizona Molina Healthcare Data Center, LLC New Mexico Molina Healthcare of Arizona, Inc. Arizona Molina Healthcare of California California Molina Healthcare of Florida, Inc. Florida Molina Healthcare of Georgia, Inc.* Georgia Molina Healthcare of Illinois, Inc. Illinois Molina Healthc
February 11, 2022	SC 13G/A	MOH / Molina Healthcare, Inc. / Capital World Investors - SEC SCHEDULE 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 10 )* Molina Healthcare, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 60855R100 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which th
February 10, 2022	SC 13G/A	MOH / Molina Healthcare, Inc. / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 7)* Name of issuer: Molina Healthcare Inc. Title of Class of Securities: Common Stock CUSIP Number: 60855R100 Date of Event Which Requires Filing of this Statement: December 31, 2021 Check the appropriate box to designate the rule pursuant to which this Schedule is filed
February 10, 2022	SC 13G/A	MOH / Molina Healthcare, Inc. / RENAISSANCE TECHNOLOGIES LLC Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 3)* MOLINA HEALTHCARE, INC. - (Name of Issuer) Common Stock, $0.001 Par Value - (Title of Class of Securities) 60855R100 - (CUSIP Number) December 31, 2021 - (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the r
February 9, 2022	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 9, 2022 (February 9, 2022) MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 1-31719 13-4204626 (State or other jurisdiction of incorpor
February 9, 2022	EX-99.1	Molina Healthcare Reports Fourth Quarter and Year-End 2021 Financial Results Introduces Full Year 2022 Earnings Guidance News Release Investor Contact: Joseph Krocheski, [email protected], 562-951-8382 Media Contact: Caroline Zubieta, [email protected], 562-951-1588 Molina Healthcare Reports Fourth Quarter and Year-End 2021 Financial Results Introduces Full Year 2022 Earnings Guidance Long Beach, Calif, February 9, 2022 ? Molina Healthcare, Inc. (NYSE: MOH) (the ?Company?) tod
February 4, 2022	SC 13G	MOH / Molina Healthcare, Inc. / WELLINGTON MANAGEMENT GROUP LLP - SEC SCHEDULE 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* MOLINA HEALTHCARE, INC. (Name of Issuer) Common Stock (Title of Class of Securities) 60855R100 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this
February 3, 2022	SC 13G/A	MOH / Molina Healthcare, Inc. / BlackRock Inc. Passive Investment us60855r1005020222.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 9) MOLINA HEALTHCARE INC - (Name of Issuer) Common Stock - (Title of Class of Securities) 60855R100 - (CUSIP Number) December 31, 2021 - (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant
January 11, 2022	CT ORDER	CT ORDER
November 16, 2021	EX-4.1	Indenture, dated as of November 16, 2021, by and between Molina Healthcare, Inc. and U.S. Bank National Association, as Trustee. US-DOCS\127593076.31203368.1 MOLINA HEALTHCARE, INC. $750,000,000 3.875% Senior Notes due 2032 INDENTURE Dated as of November 16, 2021 U.S. BANK NATIONAL ASSOCIATION as Trustee -i- US-DOCS\127593076.31203368.1 TABLE OF CONTENTS Page ARTICLE 1 DEFINITIONS AND INCORPORATION BY REFERENCE ............................................... 1 Section 1.01 Definitions. ......................................
November 16, 2021	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 16, 2021 (November 16, 2021) MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 1-31719 13-4204626 (State or other jurisdiction of incorp
November 16, 2021	EX-99.1	Molina Healthcare Announces Closing of Offering of $750 Million of 3.875% Senior Notes Due 2032 NEWS RELEASE Investor Contact: Joseph Krocheski, [email protected], 562-951-8382 Media Contact: Caroline Zubieta, [email protected], 562-951-1588 Molina Healthcare Announces Closing of Offering of $750 Million of 3.875% Senior Notes Due 2032 Long Beach, Calif., November 16, 2021 ? Molina Healthcare, Inc. (NYSE: MOH) (the ?Company?) today announced the closin
November 16, 2021	EX-99.1	Molina Healthcare Announces Closing of Offering of $750 Million of 3.875% Senior Notes Due 2032 NEWS RELEASE Investor Contact: Joseph Krocheski, [email protected], 562-951-8382 Media Contact: Caroline Zubieta, [email protected], 562-951-1588 Molina Healthcare Announces Closing of Offering of $750 Million of 3.875% Senior Notes Due 2032 Long Beach, Calif., November 16, 2021 ? Molina Healthcare, Inc. (NYSE: MOH) (the ?Company?) today announced the closin
November 16, 2021	EX-4.1	Indenture, dated as of November 16, 2021, by and between Molina Healthcare, Inc. and U.S. Bank National Association, as Trustee. US-DOCS\127593076.31203368.1 MOLINA HEALTHCARE, INC. $750,000,000 3.875% Senior Notes due 2032 INDENTURE Dated as of November 16, 2021 U.S. BANK NATIONAL ASSOCIATION as Trustee -i- US-DOCS\127593076.31203368.1 TABLE OF CONTENTS Page ARTICLE 1 DEFINITIONS AND INCORPORATION BY REFERENCE ............................................... 1 Section 1.01 Definitions. ......................................
November 16, 2021	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 16, 2021 (November 16, 2021) MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 1-31719 13-4204626 (State or other jurisdiction of incorp
November 2, 2021	EX-99.1	Molina Healthcare Announces Pricing of $750 Million of Senior Notes Due 2032 Exhibit 99.1 Molina Healthcare Announces Pricing of $750 Million of Senior Notes Due 2032 LONG BEACH, Calif.-(BUSINESS WIRE)-November 1, 2021-Molina Healthcare, Inc. (NYSE: MOH) (the ?Company?) today announced that it priced $750 million aggregate principal amount of its senior notes due 2032 (the ?Notes?) to be sold in a private offering to individuals reasonably believed to be ?qualified institu
November 2, 2021	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 2, 2021 (November 1, 2021) MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-31719 13-4204626 (State or other jurisdiction of incorp
November 2, 2021	EX-1.1	Form of Purchase Agreement, dated November 1, 2021, by and between the Company and Truist Securities, Inc., as representative of the several initial purchasers named in Schedule A thereto Exhibit 1.1 PURCHASE AGREEMENT November 1, 2021 TRUIST Securities, Inc. As Representative of the Initial Purchasers c/o Truist Securities, Inc. 3333 Peachtree Road, 11th Floor Atlanta, GA 30326 Ladies and Gentlemen: Molina Healthcare, Inc., a Delaware corporation (the ?Company?), proposes to issue and sell to Truist Securities, Inc. (?Truist?) and the other several Initial Purchasers named in Sche
November 1, 2021	8-K	Regulation FD Disclosure, Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 1, 2021 (November 1, 2021) MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-31719 13-4204626 (State or other jurisdiction of incorp
November 1, 2021	EX-99.1	Molina Healthcare Announces Proposed Offering of $750 Million of Senior Notes Due 2032 Exhibit 99.1 Molina Healthcare Announces Proposed Offering of $750 Million of Senior Notes Due 2032 LONG BEACH, Calif.-(BUSINESS WIRE)-November 1, 2021-Molina Healthcare, Inc. (NYSE: MOH) (the ?Company?) today announced that it intends to privately offer, subject to market and other conditions, $750 million aggregate principal amount of senior notes due 2032 (the ?Notes?). The Company will make th
October 28, 2021	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file numbe
October 27, 2021	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 27, 2021 (October 27, 2021) MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 1-31719 13-4204626 (State or other jurisdiction of incorpor
October 27, 2021	EX-99.1	Molina Healthcare Reports Third Quarter 2021 Financial Results Reaffirms Full Year 2021 Earnings Guidance News Release Investor Contact: Joseph Krocheski, [email protected], 562-951-8382 Media Contact: Caroline Zubieta, [email protected], 562-951-1588 Molina Healthcare Reports Third Quarter 2021 Financial Results Reaffirms Full Year 2021 Earnings Guidance Long Beach, Calif, October 27, 2021 ? Molina Healthcare, Inc. (NYSE: MOH) (the ?Company?) today reported thi
October 25, 2021	EX-99.1	Molina Healthcare Announces the Closing of its Acquisition of Affinity Health Plan NEWS RELEASE Investor Contact: Joseph Krocheski, [email protected], 562-951-8382 Media Contact: Caroline Zubieta, [email protected], 562-951-1588 Molina Healthcare Announces the Closing of its Acquisition of Affinity Health Plan Long Beach, Calif., Oct. 25, 2021 ? Molina Healthcare, Inc. (NYSE: MOH) (?Molina?) announced today that its acquisition of Affinity
October 25, 2021	8-K	Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 25, 2021 (October 25, 2021) MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 1-31719 13-4204626 (State or other jurisdiction of incorpor
October 7, 2021	EX-99.1	Molina Healthcare to Acquire Certain Assets of AgeWell New York Deal Grows Molina’s Medicaid Managed Long Term Care Presence in New York, Maintains Continuity of Care for Members and Stability for State Partners NEWS RELEASE Investor Contact: Joseph Krocheski, [email protected], 562-951-8382 Media Contact: Caroline Zubieta, [email protected], 562-951-1588 Molina Healthcare to Acquire Certain Assets of AgeWell New York Deal Grows Molina?s Medicaid Managed Long Term Care Presence in New York, Maintains Continuity of Care for Members and Stability for State Partners LO
October 7, 2021	8-K	Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 7, 2021 (October 7, 2021) MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 1-31719 13-4204626 (State or other jurisdiction of incorporat
September 17, 2021	EX-99.1	Investor Day 2021 Sustaining Profitable Growth September 17, 2021 2 Sustaining Profitable Growth Topic Speaker 8:30am Welcome and Logistics – Ron Kurtz 8:35am Sustaining Profitable Growth – Joe Zubretsky 9:30am Compelling Financial Profile – Mark Kei Investor Day 2021 Sustaining Profitable Growth September 17, 2021 2 Sustaining Profitable Growth Topic Speaker 8:30am Welcome and Logistics ? Ron Kurtz 8:35am Sustaining Profitable Growth ? Joe Zubretsky 9:30am Compelling Financial Profile ? Mark Keim 10:00am ? 10:45am Executive Q&A ? Joe Zubretsky ? Mark Keim 3 Cautionary Statement Safe Harbor Statement under the Private Securities Litigation Ref
September 17, 2021	8-K	Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 17, 2021 (September 17, 2021) MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 1-31719 13-4204626 (State or other jurisdiction of inco
September 9, 2021	EX-99.1	Molina Healthcare Signs CEO Joe Zubretsky to New Employment Agreement Exhibit 99.1 Molina Healthcare Signs CEO Joe Zubretsky to New Employment Agreement LONG BEACH, Calif.-(BUSINESS WIRE)-September 9, 2021-Molina Healthcare, Inc. (NYSE: MOH) announced today that it has entered into an amended and restated employment agreement with its President and CEO, Joe Zubretsky. The Chairman of Molina?s Board of Directors, Dale Wolf, said, ?During his nearly four-year tenure,
September 9, 2021	EX-10.1	Amended and Restated Employment Agreement, dated September 8, 2021, by and between Molina Healthcare, Inc. and Joseph M. Zubretsky. Exhibit 10.1 AMENDED AND RESTATED EMPLOYMENT AGREEMENT This Amended and Restated Employment Agreement (this ?Agreement?) is made as of September 8, 2021, between Joseph M. Zubretsky (the ?Executive?) and Molina Healthcare, Inc. (the ?Employer?). RECITALS WHEREAS, the Employer and the Executive are parties to an Employment Agreement, dated October 9, 2017 (the ?Original Agreement?), pursuant to whi
September 9, 2021	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 9, 2021 (September 8, 2021) MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-31719 13-4204626 (State or other jurisdiction of inco
August 17, 2021	8-K	Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 17, 2021 (August 17, 2021) MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 1-31719 13-4204626 (State or other jurisdiction of incorporat
August 17, 2021	EX-99.1	Molina Healthcare Awarded Nevada Medicaid Contract News Release Investor Contact: Ronald Kurtz, [email protected], 562-912-6820 Media Contact: Caroline Zubieta, [email protected], 562-951-1588 Molina Healthcare Awarded Nevada Medicaid Contract LAS VEGAS, Aug. 17, 2021 ? Molina Healthcare, Inc. (NYSE: MOH) (?Molina?) today announced its Nevada health plan subsidiary was awarded a Medicaid managed care contract fr
July 29, 2021	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 00
July 28, 2021	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 28, 2021 (July 28, 2021) MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 1-31719 13-4204626 (State or other jurisdiction of incorporation)
July 28, 2021	EX-99.1	Molina Healthcare Reports Second Quarter 2021 Financial Results Increases Full Year 2021 Earnings Guidance News Release Investor Contact: Julie Trudell, [email protected], 562-912-6720 Media Contact: Caroline Zubieta, [email protected], 562-951-1588 Molina Healthcare Reports Second Quarter 2021 Financial Results Increases Full Year 2021 Earnings Guidance Long Beach, Calif, July 28, 2021 ? Molina Healthcare, Inc. (NYSE: MOH) (the ?Company?) today reported second quar
May 11, 2021	8-K	Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 11, 2021 (May 6, 2021) MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 1-31719 13-4204626 (State or other jurisdiction of incorporation) (C
April 29, 2021	10-Q	Quarterly Report - 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 0
April 28, 2021	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 28, 2021 (April 28, 2021) MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 1-31719 13-4204626 (State or other jurisdiction of incorporatio
April 28, 2021	EX-99.1	Molina Healthcare Reports First Quarter 2021 Financial Results Increases Full Year 2021 Earnings Guidance News Release Investor Contact: Julie Trudell, [email protected], 562-912-6720 Media Contact: Caroline Zubieta, [email protected], 562-951-1588 Molina Healthcare Reports First Quarter 2021 Financial Results Increases Full Year 2021 Earnings Guidance Long Beach, Calif, April 28, 2021 ? Molina Healthcare, Inc. (NYSE: MOH) (the ?Company?) today reported first quart
April 13, 2021	EX-99.1	Molina Healthcare Wins Ohio Medicaid Contracts Exhibit 99.1 Molina Healthcare Wins Ohio Medicaid Contracts LONG BEACH, Calif.-(BUSINESS WIRE)-April 13, 2021-Molina Healthcare, Inc. (NYSE: MOH) today announced that its Ohio health plan subsidiary has been selected as an awardee in all three regions across the state pursuant to the Medicaid managed care RFA issued on September 30, 2020, by the Ohio Department of Medicaid (ODM). The new contract
April 13, 2021	8-K	Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 13, 2021 (April 13, 2021) MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-31719 13-4204626 (State or other jurisdiction of incorporat

MOH / Molina Healthcare, Inc. - SEC-Einreichungen, Geschäftsbericht, Stimmrechtsmitteilung

Continue researching MOH in the Fintel app

Grundlegende Statistiken

SEC Filings

SEC Filings (Chronological Order)

How Much do you Like Fintel?

Write a Review and get 25% Off Your Next Purchase

How can we Improve?